We are exploring a new medication for patients with advanced or metastatic solid tumors who also have moderate liver impairment. The goal is to find a safe starting dose for this treatment.
Health conditions and diseases that the clinical trial is designed to study and treat.
Solid tumors are abnormal masses of tissue that can occur in various parts of the body and are characterized by the uncontrolled growth of cells. They can be benign (non-cancerous) or malignant (cancerous), leading to various symptoms depending on their location.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.